HF
Hannah Fry
VP, Principal Accounting Officer & ControllerMs. Hannah Fry serves as Vice President, Controller and Principal Accounting Officer of Protara Therapeutics, Inc. from July 16, 2022. She joined the Protara Therapeutics, Inc. in April 2020. Prior to her appointment as Controller, served in various roles reporting directly to the Chief Financial Officer of the Company, most recently as Senior Director, Assistant Controller. Prior to joining the company she worked in public accounting, most recently with member firms of Deloitte Touche Tohmatsu Limited from 2014 to 2020, leading audits of complex publicly traded entities. Ms. Fry received her B.S. in Accountancy from the University of San Diego. She is a licensed Certified Public Accountant in the State of California.
Positions
- Company NameProtara Therapeutics, Inc.Stock CodeTARAPositionVP, Principal Accounting Officer & ControllerColleagues
- JSJesse SheffermanCo-founder, CEO, President & Director
- LMLuke M. BesharIndependent Chairman of the Board
- JZJacqueline ZummoCo-Founder, Chief R&D Officer
- PFPatrick FabbioChief Financial Officer
- JOJustine O’MalleySenior Vice President of Investor Relations & Corporate Affairs
- GPGregory P. SargenIndependent Director
- CSCynthia SmithIndependent Director
- RJRoger J. GarceauIndependent Director
